New York City-based NYU Langone has appointed Noritsugu Naito, MD, PhD, to serve as NYU Langone Hospital-Brooklyn’s first ...

The National Lipid Association (NLA) and the American Geriatrics Society (AGS) have released a Joint Scientific Statement ...

PERCUTANEOUS coronary intervention (PCI) for unprotected left main coronary artery (ULMCA) disease demonstrates favourable ...

Researchers from Philadelphia-based University of Pennsylvania’s Leonard Davis Institute of Health Economics recently found ...

With tax season here, physicians juggling hectic clinical schedules must also focus ... discusses notable updates across several areas of cardiology he presented at the ACP Internal Medicine ...

The following is a summary of “Cardiac Arrest Management in United States Emergency Departments During the First Year of the ...

After 2024, which saw a steady recovery by the life sciences industry, it looks like 2025 is set to be a year of change and development, particularly in clinical trials. The good news is that ...

The study of lipids in cardiovascular disease is a critical area of medical research, offering insights into the mechanisms through which altered lipid ...

Correspondence to Dr Thomas Bandholm, Dept of Clinical Research, Copenhagen University Hospital ... We suggest you consult The Cochrane Handbook for Systematic Reviews of Interventions.40 It provides ...

CHICAGO — In a phase 2b study, treatment with a once-daily oral PCSK9 inhibitor added to statin therapy resulted in a more than 50% reduction in LDL cholesterol at 12 weeks in patients with ...

In this interview, Gilles Montalescot, MD, PhD, discusses the significant impact of US funding cuts on global medical research and the potential for Europe to step in.